Redcare Pharmacy NV
Redcare Pharmacy NV Fundamental Analysis
Redcare Pharmacy NV (SHPPF) shows moderate financial fundamentals with a PE ratio of -20.93, profit margin of -1.28%, and ROE of -7.76%. The company generates $3.0B in annual revenue with strong year-over-year growth of 31.79%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 23.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze SHPPF's fundamental strength across five key dimensions:
Efficiency Score
WeakSHPPF struggles to generate sufficient returns from assets.
Valuation Score
ModerateSHPPF shows balanced valuation metrics.
Growth Score
ModerateSHPPF shows steady but slowing expansion.
Financial Health Score
ExcellentSHPPF maintains a strong and stable balance sheet.
Profitability Score
WeakSHPPF struggles to sustain strong margins.
Key Financial Metrics
Is SHPPF Expensive or Cheap?
P/E Ratio
SHPPF trades at -20.93 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, SHPPF's PEG of 3.52 indicates potential overvaluation.
Price to Book
The market values Redcare Pharmacy NV at 1.72 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 7.24 times EBITDA. This is generally considered low.
How Well Does SHPPF Make Money?
Net Profit Margin
For every $100 in sales, Redcare Pharmacy NV keeps $-1.28 as profit after all expenses.
Operating Margin
Core operations generate -0.97 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-7.76 in profit for every $100 of shareholder equity.
ROA
Redcare Pharmacy NV generates $-3.02 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Redcare Pharmacy NV generates limited operating cash flow of $27.39M, signaling weaker underlying cash strength.
Free Cash Flow
Redcare Pharmacy NV generates weak or negative free cash flow of $-82.15M, restricting financial flexibility.
FCF Per Share
Each share generates $-4.04 in free cash annually.
FCF Yield
SHPPF converts -10.18% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-20.93
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
3.52
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.72
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.27
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.91
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.55
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-0.08
vs 25 benchmark
ROA
Return on assets percentage
-0.03
vs 25 benchmark
ROCE
Return on capital employed
-0.03
vs 25 benchmark
How SHPPF Stacks Against Its Sector Peers
| Metric | SHPPF Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -20.93 | 28.45 | Better (Cheaper) |
| ROE | -7.76% | 763.00% | Weak |
| Net Margin | -1.28% | -45265.00% (disorted) | Weak |
| Debt/Equity | 0.91 | 0.34 | Weak (High Leverage) |
| Current Ratio | 1.55 | 2795.60 | Neutral |
| ROA | -3.02% | -16588.00% (disorted) | Weak |
SHPPF outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Redcare Pharmacy NV's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
120.30%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
18.34%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
147.47%
Industry Style: Defensive, Growth, Innovation
High Growth